Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Prepaid Assets (2019 - 2025)

Historic Prepaid Assets for Madrigal Pharmaceuticals (MDGL) over the last 14 years, with Q3 2025 value amounting to $49.3 million.

  • Madrigal Pharmaceuticals' Prepaid Assets rose 13646.52% to $49.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.3 million, marking a year-over-year increase of 13646.52%. This contributed to the annual value of $13.8 million for FY2024, which is 33765.08% up from last year.
  • Madrigal Pharmaceuticals' Prepaid Assets amounted to $49.3 million in Q3 2025, which was up 13646.52% from $58.6 million recorded in Q2 2025.
  • In the past 5 years, Madrigal Pharmaceuticals' Prepaid Assets ranged from a high of $58.6 million in Q2 2025 and a low of $822000.0 during Q1 2021
  • Over the past 5 years, Madrigal Pharmaceuticals' median Prepaid Assets value was $3.2 million (recorded in 2023), while the average stood at $11.8 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first plummeted by 2045.92% in 2023, then surged by 67670.17% in 2024.
  • Madrigal Pharmaceuticals' Prepaid Assets (Quarter) stood at $1.3 million in 2021, then soared by 93.95% to $2.6 million in 2022, then grew by 21.39% to $3.2 million in 2023, then surged by 337.65% to $13.8 million in 2024, then soared by 257.82% to $49.3 million in 2025.
  • Its Prepaid Assets stands at $49.3 million for Q3 2025, versus $58.6 million for Q2 2025 and $23.2 million for Q1 2025.